Clinical activity of the oral ALK and MET inhibitor PF-02341066 in non-small lung cancer (NSCLC) with EML4-ALK translocations Meeting Abstract
| Authors: | Shaw, A. T.; Costa, D. B.; Iafrate, A. J.; Dezube, B. J.; Shapiro, G. I.; Bang, Y. J.; Jänne, P. A.; Lynch, T. J.; Maki, R. G.; Camidge, D. R.; Solomon, B.; Kwak, E. L.; Tan, W. W.; Chen, I.; Christensen, J.; Wilner, K.; Clark, J. W.; Salgia, R. |
| Abstract Title: | Clinical activity of the oral ALK and MET inhibitor PF-02341066 in non-small lung cancer (NSCLC) with EML4-ALK translocations |
| Meeting Title: | 13th World Conference on Lung Cancer (IASLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 4 |
| Issue: | 9 Suppl. 1 |
| Meeting Dates: | 2009 Jul 31-Aug 4 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2009-09-01 |
| Start Page: | S305 |
| End Page: | S306 |
| Language: | English |
| ACCESSION: | ISI:000269496000317 |
| PROVIDER: | wos |
| PUBMED: | 19704333 |
| DOI: | 10.1097/JTO.0b013e3181b9c77e |
| Notes: | Meeting Abstract: A6.4 - Suppl. 1 - "Source: Wos" |
